Search details
1.
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment.
J Transl Med
; 21(1): 273, 2023 04 21.
Article
in English
| MEDLINE | ID: mdl-37085802
2.
Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.
J Transl Med
; 20(1): 290, 2022 06 27.
Article
in English
| MEDLINE | ID: mdl-35761360
3.
Novel pathways involved in cisplatin resistance identified by a proteomics approach in non-small-cell lung cancer cells.
J Cell Physiol
; 234(6): 9077-9092, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30362533
4.
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
BMC Cancer
; 16(1): 918, 2016 11 25.
Article
in English
| MEDLINE | ID: mdl-27884140
5.
New perspective for an old antidiabetic drug: metformin as anticancer agent.
Cancer Treat Res
; 159: 355-76, 2014.
Article
in English
| MEDLINE | ID: mdl-24114491
6.
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
J Exp Clin Cancer Res
; 43(1): 137, 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38711119
7.
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness-A Practical Preventing Recommendation and Therapies.
Nutrients
; 15(3)2023 Jan 21.
Article
in English
| MEDLINE | ID: mdl-36771270
8.
ß2-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery.
Cell Death Dis
; 14(9): 613, 2023 09 19.
Article
in English
| MEDLINE | ID: mdl-37723219
9.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
J Exp Clin Cancer Res
; 41(1): 83, 2022 Mar 03.
Article
in English
| MEDLINE | ID: mdl-35241126
10.
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?
J Cardiovasc Dev Dis
; 9(12)2022 Nov 28.
Article
in English
| MEDLINE | ID: mdl-36547420
11.
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.
Proteomics
; 11(18): 3725-42, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21761561
12.
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
J Cell Physiol
; 226(9): 2378-90, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21660961
13.
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Mol Oncol
; 15(4): 1005-1023, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33331136
14.
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Front Cell Dev Biol
; 8: 732, 2020.
Article
in English
| MEDLINE | ID: mdl-33015030
15.
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
J Exp Clin Cancer Res
; 39(1): 213, 2020 Oct 08.
Article
in English
| MEDLINE | ID: mdl-33032653
16.
Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.
Mol Cancer Ther
; 18(8): 1405-1417, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31189612
17.
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
J Exp Clin Cancer Res
; 38(1): 317, 2019 Jul 18.
Article
in English
| MEDLINE | ID: mdl-31319863
18.
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
Recent Pat Anticancer Drug Discov
; 13(2): 184-200, 2018.
Article
in English
| MEDLINE | ID: mdl-29189178
19.
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
Clin Cancer Res
; 12(2): 617-25, 2006 Jan 15.
Article
in English
| MEDLINE | ID: mdl-16428508
20.
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53.
J Exp Clin Cancer Res
; 36(1): 177, 2017 Dec 06.
Article
in English
| MEDLINE | ID: mdl-29212503